Acrochordons May Be Marker for Metabolic Disease in Children
By Elana Gotkine HealthDay Reporter
TUESDAY, May 21, 2024 -- In pediatric patients, acrochordons may be a marker for metabolic disease, according to a study published online April 29 in Pediatric Dermatology.
Rachel K. Greene, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a single-center retrospective cohort study of outpatient dermatology patients between Jan. 1, 2000, and Jan. 1, 2021, to examine the association between acrochordons, obesity, and metabolic syndrome. Children diagnosed with acrochordons were identified.
The 55 patients younger than 18 years (mean age of diagnosis, 10.1 years) with acrochordon diagnosis were mainly Caucasian and female (76 and 64 percent, respectively). Mean body mass index was 27.3 kg/m2; 49.5 and 20 percent of participants were categorized as overweight and obese, respectively. The researchers found that acrochordon mainly appeared in the axilla. Three patients in the cohort (5.5 percent) met the criteria for metabolic syndrome. Compared with a sample from the National Health and Nutrition Examination Survey, the prevalence rates of obesity (42 versus 21 percent), type 2 diabetes mellitus (4.8 versus 0.6 percent), hyperlipidemia (8.1 versus 0 percent), and hypertension (1.6 versus 0 percent) were higher in the study cohort.
"While skin tags are largely benign and idiopathic, their presence may indicate underlying metabolic abnormalities in both adults and children, especially in the setting of obesity," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea
FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among...
Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMD
THURSDAY, June 27, 2024 -- For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective...
ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA
WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.